https://www.selleckchem.com/Proteasome.html
Copyright © 2020 Sarode, Schaefer, Grimminger, Seeger and Savai.Recent development of integrative therapy against melanoma combines surgery, radiotherapy, targeted therapy, and immunotherapy; however, the clinical outcomes of advanced stage and recurrent melanoma are poor. As a skin cancer, melanoma is generally resistant to radiotherapy. Hence, there is an urgent need for evaluation of the mechanisms of radioresistance. The present study identified miR-335 as one of the differential expression of miRNAs in recurrent melanoma biopsies post-ra
Curtir
Comentario
Compartilhar
